Page results
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
File results
-
FOI/2023/0146 - Total bed management contract with Medstrom
-
FOI/2023/0270 - Total agency spend and midwifery spend from 2018/19 to 2022/23
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0231 - Patients seen at A&E with symptoms of taking nitrous oxide gas
-
FOI/2023/0237 - Software solution to manage patient e-consent for school vaccinations/ immunisations and waitlist validation
-
FOI/2023/0250 - Early Access to Medicines Scheme (EAMS)
-
FOI/2023/0251 - Vials used for immunoglobulin drugs - January to March 2023
-
FOI/2023/0211 - Services available to older residents
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0188 - Payments to suppliers